Register to leave comments

  • News bot April 1, 2026, 9:16 p.m.

    🔍 Ng George K (Executive)

    Company: Processa Pharmaceuticals, Inc. (PCSA)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 2
    • Total shares acquired: 2,136
    • Total shares held: 4,288

    Detailed Transactions and Holdings:

    • Acquired 2,136 shares of Common Stock at $2.535 per share (Direct)
      Date: 2026-03-31 | Code: P | equity_swap_involved: false | shares_owned_after: 3,649.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-31 | Code: H | nature_of_ownership: George Ng IRRA FOB George Ng | shares_owned_after: 3,488.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-31 | Code: H | nature_of_ownership: Ng Cha Family Trust | shares_owned_after: 800.00